Search Results

No Results

    Recently Viewed

      Listening...

      Sorry, I don't understand. Please try again
      Home
      /
      Latest news
      /
      Innovation
      /
      Innovation-opedia: What is a mosaic vaccine?
      Graphic featuring a syringe to illustrate an HIV vaccine trial
      Innovation

      Innovation-opedia: What is a mosaic vaccine?

      As the IAS Conference on HIV Science kicks off in Mexico City, we explain how an investigational HIV vaccine from the Janssen Pharmaceutical Companies of Johnson & Johnson works—and how researchers hope to help change lives around the world with it.

      Written by Johnson & Johnson
       | July 22, 2019
      July 22, 2019
      Illustrated handwritten definition of a mosaic HIV vaccine
      Illustration of a microscope with information about Janssen Vaccines & Prevention B.V. investigational HIV-1 vaccine regimen
      Inset- Innovation-opedia: What Is a Mosaic Vaccine?- mosaic-vaccine-4-immunizations_above
      Illustration of the # 4 explaining how many injections would be administered for Janssen’s investigational HIV-1 vaccine.
      Inset- Innovation-opedia: What Is a Mosaic Vaccine?- mosaic-vaccine-4-immunizations_below
      Illustration showing location of the IAS Conference on HIV Science with details about Janssen’s new Mosaico clinical trial.
      Illustrated quote by Janssen’s Maria Grazia Pau talking about the goal of creating a global HIV vaccine.

      We’re committed to helping lead the fight against HIV/AIDS

      Read about the many ways Johnson & Johnson is working to #makeHIVhistory.
      Learn more
      CTA-Red ribbon HIV

      HIV vaccine HIV/AIDS J&J Innovative Medicine Johnson & Johnson

      More from Johnson & Johnson

      Innovation
      November 26, 2024

      This scientist couldn’t save his father from lung cancer—but the targeted treatments Robert Zhao, Ph.D., has since developed have helped countless others

      Learn more about Zhao, his partnership with Johnson & Johnson and antibody-drug conjugates—a new type of cancer therapy that targets and kills cancer cells without harming healthy cells.
      Read more
      Innovation
      November 25, 2024

      After their husbands were diagnosed with multiple myeloma, these 3 care partners became health equity activists

      Kimberly Alexander, Michelle Ware-Ivy and Marsha Calloway-Campbell learned firsthand that Black individuals develop multiple myeloma at higher rates. That’s why they joined Johnson & Johnson’s That’s My Word® health equity campaign, which builds awareness about the disparities surrounding this rare blood cancer.
      Read more
      Latest news
      November 19, 2024

      How Johnson & Johnson is working to get medications to people around the world who need them most

      In the just-released 2024 Access to Medicine Index, the company ranks among the top 5 improving access to medicines.
      Read more